59 results
8-K
EX-10.1
XERS
Xeris Pharmaceuticals Inc
5 Oct 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
j2tas6gu8 67rol
29 Jul 21
Xeris Pharmaceuticals Announces Executive Changes As Part of Its Strategy to Position the Company for Long-term Commercial Success
12:00am
8-K
EX-10.2
9p8px vlq
29 Jul 21
Xeris Pharmaceuticals Announces Executive Changes As Part of Its Strategy to Position the Company for Long-term Commercial Success
12:00am
8-K
EX-10.1
e09fiw
24 May 21
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
7:11am
8-K
EX-10.2
7wybkl1 mvn8
24 May 21
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
7:11am
8-K
EX-10.4
9bwk59djka
24 May 21
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
7:11am
8-K
EX-10.3
e5srqsfkdv
24 May 21
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
7:11am
8-K
EX-10.1
6pe0kyj7yel hx
11 Mar 21
Xeris Pharmaceuticals Announces Pricing of $27.0 Million
7:09am
8-K
EX-10.1
2ty6snmpe
16 Nov 20
Unregistered Sales of Equity Securities
7:26am